FOREST LABORATORIES, INC. AND GEDEON RICHTER ANNOUNCE POSITIVE RESULTS FROM A PHASE IIB STUDY OF CARIPRAZINE FOR THE TREATMENT OF SCHIZOPHRENIA.Published in:Psychiatry (1550-5952), 2009, v. 6, n. 11, p. 11Publication type:Article